See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $10.1B | n/a | n/a | |
| $8.6B | 7.1x | 20.4x | |
| $1.6B | 5.7x | -11.0x | |
| $1.5B | 7.4x | -24.5x | |
| $977M | n/a | n/a | |
| $195M | 2775.0x | -5.7x | |
| $187M | 10.2x | 13.3x | |
| $168M | n/a | n/a | |
| $47.2M | 2.8x | 14.0x | |
| $41.2M | 16.2x | -10.1x | |
| $19.2M | 14.4x | -9.0x | |
| $17.9M | n/a | n/a | |
| $6.0M | n/a | n/a | |
| -$16.8M | n/a | 0.2x | |
| -$23.4M | -0.9x | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics